Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix

M. Vosmik, J. Laco, I. Sirak, M. Beranek, E. Hovorkova, H. Vosmikova, M. Drastikova, M. Hodek, Z. Zoul, K. Odrazka, J. Petera,

. 2014 ; 20 (1) : 131-7.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008583

The aim of the retrospective study was to evaluate prognostic significance of human papillomavirus (HPV) status and expression of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor type 2 (HER2/neu), vascular endothelial growth factor (VEGF), CD34 antigen, tumor suppressors p63 and p53, and Ki67/MIB-1 in squamous cell carcinoma of the uterine cervix (SCCC) treated with radiotherapy or chemoradiotherapy. Seventy-two consecutive patients with SCCC, diagnosed and treated with (chemo-) radiotherapy with a curative intent at the University Hospital Hradec Kralove between August 1998 and August 2008, were enrolled in the study. The median follow-up period was 57 months (range 5-152). The tested biological factors were evaluated by polymerase chain reaction (HPV status) and by immunohistochemistry (remaining above mentioned markers) from archival paraffin embedded original diagnostic tumor samples. A statistical significant correlation was observed between low expression of p63 and poor overall survival (p = 0.001), although the complete response probability was influenced with borderline statistical significance (p = 0.05). However, the results could be affected by the statistical error due to the small number of p63 negative patients. HPV positivity and EGFR staining intensity was associated with higher complete response probability (p = 0.038 and p = 0.044, resp.). All other results were not significant. Neither HPV positivity nor EGFR staining intensity were reflected in the overall survival evaluation. In conclusion, the presented study did not confirm any apparently significant association of the suggested markers with prognosis of SCCC in patients treated with (chemo-) radiotherapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008583
003      
CZ-PrNML
005      
20240904092446.0
007      
ta
008      
150306s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12253-013-9674-5 $2 doi
035    __
$a (PubMed)23913252
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Vosmik, Milan $u Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Sokolská 581, 500 05, Hradec Kralove, Czech Republic, milan.vosmik@fnhk.cz.
245    10
$a Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix / $c M. Vosmik, J. Laco, I. Sirak, M. Beranek, E. Hovorkova, H. Vosmikova, M. Drastikova, M. Hodek, Z. Zoul, K. Odrazka, J. Petera,
520    9_
$a The aim of the retrospective study was to evaluate prognostic significance of human papillomavirus (HPV) status and expression of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor type 2 (HER2/neu), vascular endothelial growth factor (VEGF), CD34 antigen, tumor suppressors p63 and p53, and Ki67/MIB-1 in squamous cell carcinoma of the uterine cervix (SCCC) treated with radiotherapy or chemoradiotherapy. Seventy-two consecutive patients with SCCC, diagnosed and treated with (chemo-) radiotherapy with a curative intent at the University Hospital Hradec Kralove between August 1998 and August 2008, were enrolled in the study. The median follow-up period was 57 months (range 5-152). The tested biological factors were evaluated by polymerase chain reaction (HPV status) and by immunohistochemistry (remaining above mentioned markers) from archival paraffin embedded original diagnostic tumor samples. A statistical significant correlation was observed between low expression of p63 and poor overall survival (p = 0.001), although the complete response probability was influenced with borderline statistical significance (p = 0.05). However, the results could be affected by the statistical error due to the small number of p63 negative patients. HPV positivity and EGFR staining intensity was associated with higher complete response probability (p = 0.038 and p = 0.044, resp.). All other results were not significant. Neither HPV positivity nor EGFR staining intensity were reflected in the overall survival evaluation. In conclusion, the presented study did not confirm any apparently significant association of the suggested markers with prognosis of SCCC in patients treated with (chemo-) radiotherapy.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a antigeny CD34 $x genetika $7 D018952
650    _2
$a spinocelulární karcinom $x genetika $x patologie $x radioterapie $x virologie $7 D002294
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a exprese genu $7 D015870
650    _2
$a lidé $7 D006801
650    _2
$a antigen Ki-67 $x genetika $7 D019394
650    _2
$a membránové proteiny $x genetika $7 D008565
650    _2
$a lidé středního věku $7 D008875
650    _2
$a Papillomaviridae $x izolace a purifikace $7 D027383
650    _2
$a infekce papilomavirem $x genetika $x patologie $x virologie $7 D030361
650    _2
$a prognóza $7 D011379
650    _2
$a erbB receptory $x genetika $7 D066246
650    _2
$a receptor erbB-2 $x genetika $7 D018719
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a nádorové biomarkery $x genetika $7 D014408
650    _2
$a nádorový supresorový protein p53 $x genetika $7 D016159
650    _2
$a nádory děložního čípku $x genetika $x patologie $x radioterapie $x virologie $7 D002583
650    _2
$a vaskulární endoteliální růstový faktor A $x genetika $7 D042461
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Laco, Jan
700    1_
$a Sirak, Igor
700    1_
$a Beranek, Martin
700    1_
$a Hovorkova, Eva
700    1_
$a Vosmikova, Hana
700    1_
$a Drastíková, Monika $7 xx0321911
700    1_
$a Hodek, Miroslav
700    1_
$a Zoul, Zdenek
700    1_
$a Odrazka, Karel
700    1_
$a Petera, Jiri
773    0_
$w MED00180530 $t Pathology oncology research $x 1532-2807 $g Roč. 20, č. 1 (2014), s. 131-7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23913252 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20240904092442 $b ABA008
999    __
$a ok $b bmc $g 1065856 $s 891383
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 20 $c 1 $d 131-7 $i 1532-2807 $m Pathology oncology research $n Pathol Oncol Res $x MED00180530
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...